Evidence map›Paper›PMID 41779175›Full record

ArticlePediatric cardiology2026

Prenatally vs. Postnatally Diagnosed Congenitally Corrected Transposition of the Great Arteries is Associated with Higher Rates of Conduction Disease, Intervention and Earlier Mortality.

Lynne E Nield, Mélanie Grasswill, Bénédicte Romefort, Solène Prigent, Emre Belli, Sonya V Babu-Narayan, Robert W Elder, Magalie Ladouceur, Paul Khairy, Ewa Kowalik and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Lynne E NieldDivision of Cardiology, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Mélanie GrasswillDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, F-44000, France.
Bénédicte RomefortDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, F-44000, France.
Solène PrigentDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, F-44000, France.
Emre BelliDepartment of Pediatric and Adult Congenital Heart Disease, M3C Marie Lannelongue Hospital, Groupe Hospitalier Saint Joseph, Paris, France.
Sonya V Babu-NarayanNational Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, London, UK.
Robert W ElderDepartment of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
Magalie LadouceurDivision of Cardiology, Geneva University Hospital, Geneva, Switzerland.
Paul KhairyElectrophysiology Service and Adult Congenital Heart Center, Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.
Ewa KowalikDepartment of Congenital Heart Diseases, National Institute of Cardiology, Warsaw, Poland.
David M KalfaDepartment of Pediatric and Congenital Cardiac Surgery, Morgan Stanley Children's Hospital - New York Presbyterian, Columbia University Medical Center, New York, NY, USA.
Miriam ConwayNational Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, London, UK.
Oscar WernerDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, F-44000, France.
Jean-Marc SellalDepartment of Cardiology, CHRU-Nancy, Université de Lorraine, Nancy, France.
Astrid MonierDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, F-44000, France.
Edward BurattoDepartment of Paediatrics, The University of Melbourne, Melbourne, Australia.
Paul PadovaniDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, F-44000, France.
David J BarronDepartment of Congenital Heart Disease, Evelina London Children's Hospital, Guy's & St Thomas' Hospital, London, UK.
Emile A BachaDepartment of Pediatric and Congenital Cardiac Surgery, Morgan Stanley Children's Hospital - New York Presbyterian, Columbia University Medical Center, New York, NY, USA.
Michael A GatzoulisNational Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, London, UK.
Christopher J McLeodDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Matilde KarakachoffClinique des Données, CHU Nantes, INSERM, CIC 1413, Nantes, 44093, CIC, France.
Alban-Elouen BaruteauDepartment of Pediatric Cardiology and Pediatric Cardiac Surgery, Nantes Université, CHU Nantes, FHU PreciCare, Nantes, F-44000, France. albanelouen.baruteau@chu-nantes.fr.
DISCO study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenitally corrected transposition of the great arteries (ccTGA) with biventricular physiology is presumed to carry a favorable outcome. We aimed to explore the differences in associated diagnoses (including conduction disease), management and outcomes among prenatally vs. postnatally diagnosed ccTGA cases. Secondary objective was to examine outcomes in isolated ccTGA. An international, multicenter, retrospective cohort study was conducted in 29 tertiary hospitals (6 countries) from 1990 to 2018. Patients with a single ventricle, heterotaxy syndrome, or valvar atresia were excluded. Of 331 ccTGA patients with a median follow-up of 8.6 years [IQR: 3.5–14.1], 128 (38.7%) were diagnosed prenatally at a median gestational age of 22 weeks. As compared to the postnatal group, prenatally diagnosed patients experienced earlier cardiac conduction disorders (median age at diagnosis of conduction disorders: 0.3 versus 2.7 years, p = 0.010), earlier pacemaker implantation (median age at pacing: 6.5 years [2.5–11.6] versus 0.9 year [0.1-3.0], p < 0.001) and earlier surgical intervention (intervention-free survival rate at 3 years: 50.3% versus 34.7%, p < 0.001). The 3-year survival rate was significantly lower in patients diagnosed prenatally (91.1% versus 98.4%, p = 0.002) and the median age at death was significantly younger among patients diagnosed prenatally (0.2 versus 7.0 years, p < 0.001). In both groups, isolated ccTGA (n = 63, 19%) was associated with superior outcomes with no intervention in 46.8% and only one death. Prenatally diagnosed patients with ccTGA had earlier conduction disorders and interventions than postnatally diagnosed patients and died at a younger age. Outcomes were best in patients with isolated ccTGA.

Indexed as

Congenital heart diseaseCongenitally corrected transposition of the great arteriesHeart blockPrenatal diagnosisVentricular discordance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.